Friday, July 10, 2026

biotech · Propionic Acidemia · Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency

SOM Biotech

SOM Biotech clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Barcelona, ES HQ
2009 Founded
14 Employees
EMA registrant Type
Company details
Intelligence · Clinical Programs

SOM Biotech projects

3 ClinicalTrials.gov programs sponsored by SOM Biotech.

SOM Biotech has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. mRNA-1010

    Moderna Biotech Spain

    Seasonal Influenza

    phase 3 mab completed

    1 trial
  2. mRNA-1010-P304

    Moderna Biotech Spain

    Influenza

    phase 3 small molecule active

    1 trial
  3. mRNA1647-P301

    Moderna Biotech Spain

    Cytomegalovirus Infection (CMV)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does SOM Biotech have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.